Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,613 | 0 | 0 | 0 | 17,501 |
| Marketable Securities | N/A | 0 | 0 | 0 | 7,386 |
| Other current assets | 0 | 0 | 0 | 0 | 519 |
| TOTAL | $55,025 | $0 | $0 | $0 | $25,406 |
| Non-Current Assets | |||||
| PPE Net | 69 | N/A | N/A | N/A | 133 |
| Other Non-Current Assets | 127 | 0 | 0 | 0 | 20 |
| TOTAL | $196 | $N/A | $N/A | $N/A | $153 |
| Total Assets | $55,221 | $0 | $0 | $0 | $25,505 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 908 | 0 | 0 | 0 | 542 |
| Accrued Expenses | 3,672 | 0 | 0 | 0 | 2,397 |
| TOTAL | $4,580 | $0 | $0 | $0 | $2,939 |
| Non-Current Liabilities | |||||
| TOTAL | $36 | $N/A | $N/A | $N/A | $41 |
| Total Liabilities | $4,616 | $0 | $0 | $0 | $2,980 |
| Shareholders' Equity | |||||
| Retained earnings | -44,958 | 0 | 0 | 0 | -25,493 |
| Other shareholders' equity | 92,720 | 0 | 0 | 0 | 45,655 |
| TOTAL | $50,605 | $0 | $0 | $0 | $22,525 |
| Total Liabilities And Equity | $55,221 | $0 | $0 | $0 | $25,505 |